The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood 2011 Oct 27;118(17):4663-5
Date
09/02/2011Pubmed ID
21881050DOI
10.1182/blood-2011-06-362392Scopus ID
2-s2.0-80055076037 103 CitationsAbstract
The POEMS syndrome is associated with elevated vascular endothelial growth factor (VEGF) levels. Several studies have compared serum VEGF levels between POEMS patients and other disease entities showing higher serum VEGF in POEMS syndrome; however, it is unknown whether serum levels are reliable and reproducible given variable platelet release of VEGF. We therefore compared plasma levels of VEGF in 29 patients with POEMS syndrome with those of other disorders (n = 76). We demonstrated that plasma VEGF levels are useful in differentiating POEMS from other plasma cell dyscrasias, neuropathic processes, and multisystem illnesses. Plasma VEGF is also useful in monitoring disease activity after treatment and correlates with clinical improvements better than hematologic response.
Author List
D'Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, Kyle RA, Kumar S, Greipp PR, Lust JA, Russell SJ, Zeldenrust S, Dingli D, Witzig TE, Rajkumar SV, Dispenzieri AAuthor
Anita D'Souza MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Castleman DiseaseCohort Studies
Follow-Up Studies
Humans
Monoclonal Gammopathy of Undetermined Significance
POEMS Syndrome
Polyneuropathies
Predictive Value of Tests
Remission Induction
Retrospective Studies
Vascular Endothelial Growth Factor A
